Source link : https://newshealth.biz/health-news/orforglipron-lowers-a1c-weight-in-early-type-2-diabetes/
CHICAGO — The investigational non-peptide small-molecule oral GLP-1 agonist orforglipron significantly reduced A1c over 40 weeks in adults with early type 2 diabetes, according to the results of ACHIEVE-1 sponsored by Eli Lilly. In the trial, orforglipron reduced A1c to the 6.5% range and produced clinically meaningful weight loss with a safety profile similar to […]
The post Orforglipron Lowers A1c, Weight in Early Type 2 Diabetes first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-21 23:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8